No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
AURA Aura Biosciences
- 7.150
- -0.220-2.99%
Close Jul 2 16:00 ET
- 7.300
- +0.150+2.10%
Post 18:50 ET
354.23MMarket Cap-3823P/E (TTM)
7.375High7.150Low70.89KVolume7.320Open7.370Pre Close512.12KTurnover0.23%Turnover RatioLossP/E (Static)49.54MShares12.50052wk High1.70P/B220.61MFloat Cap5.99052wk Low--Dividend TTM30.85MShs Float26.160Historical High--Div YieldTTM3.05%Amplitude5.990Historical Low7.224Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Aura Biosciences | 10-K/A: Annual report (Amendment)
Aura Biosciences to Participate in the Jefferies Global Healthcare Conference
BOSTON, May 30, 2024 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ:AURA), a clinical-stage biotechnology company developing precision immunotherapies to treat solid tumors designed to preserve the function of the
Analysts Offer Insights on Healthcare Companies: Aura Biosciences Inc (AURA), Collplant Holdings (CLGN) and Zimmer Biomet Holdings (ZBH)
Aura Biosciences to Host Virtual KOL Event "Pioneering a New Standard of Care In Ocular Oncology" on May 29, 2024
BOSTON, May 23, 2024 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision immunotherapies to treat solid tumors designed to preserve
JMP Securities Maintains Aura Biosciences(AURA.US) With Buy Rating, Maintains Target Price $19
JMP Securities analyst Jonathan Wolleben maintains $Aura Biosciences(AURA.US)$ with a buy rating, and maintains the target price at $19.According to TipRanks data, the analyst has a success rate of 42
Analysts' Opinions Are Mixed on These Healthcare Stocks: Generation Bio (GBIO), LAVA Therapeutics (LVTX) and Aura Biosciences Inc (AURA)
Comments
Recent insider selling at Aura Biosciences raises caution, despite positive insider transactions over the past year. Low insider ownership suggests misalignment with shareholder interests. The company's outlook is not promising, with 5 warning signs investors should note.
Aura Biosciences Insider Ups Holding By 232% During Year 1
Gapping up
In reaction to earnings/guidance:
• $Nutanix(NTNX.US$ +15.4%, $Pure Storage(PSTG.US$ +6.8%, $Credo Technology(CRDO.US$ +5.9%, $Signet Jewelers(SIG.US$ +3.6%, $SentinelOne(S.US$ +3.4%, $Five Below(FIVE.US$ +3.2%, $GMS Inc(GMS.US$ +1.7%, $The Scotts Miracle(SMG.US$ +0.9% (also CFO steps down, lowers FY22 FCF guidance, reaffirms all other guidance)
Other news:
• $Turquoise Hill Resources(TRQ.US$ +12.3% (to be acquired by Rio T...
In reaction to earnings/guidance:
• $Nutanix(NTNX.US$ +15.4%, $Pure Storage(PSTG.US$ +6.8%, $Credo Technology(CRDO.US$ +5.9%, $Signet Jewelers(SIG.US$ +3.6%, $SentinelOne(S.US$ +3.4%, $Five Below(FIVE.US$ +3.2%, $GMS Inc(GMS.US$ +1.7%, $The Scotts Miracle(SMG.US$ +0.9% (also CFO steps down, lowers FY22 FCF guidance, reaffirms all other guidance)
Other news:
• $Turquoise Hill Resources(TRQ.US$ +12.3% (to be acquired by Rio T...
9
Gainers:
• $Aura Biosciences(AURA.US$ +13.9% (reports topline data from study of AU-011)
• $Hyzon Motors(HYZN.US$ +8.2% (to collaborate with $Schlumberger(SLB.US$ in decarbonizing oil & gas field operations with high-power fuel cells)
• $Apogee Enterprises(APOG.US$ +6.3% (In reaction to earnings/guidance)
• $GMS Inc(GMS.US$ +6% (In reaction to earnings/guidance)
• $Darden Restaurants(DRI.US$ +4.2% (In reaction to earnings/gui...
• $Aura Biosciences(AURA.US$ +13.9% (reports topline data from study of AU-011)
• $Hyzon Motors(HYZN.US$ +8.2% (to collaborate with $Schlumberger(SLB.US$ in decarbonizing oil & gas field operations with high-power fuel cells)
• $Apogee Enterprises(APOG.US$ +6.3% (In reaction to earnings/guidance)
• $GMS Inc(GMS.US$ +6% (In reaction to earnings/guidance)
• $Darden Restaurants(DRI.US$ +4.2% (In reaction to earnings/gui...
9
2
Related:
IPO-pedia | Chipmaker giant GlobalFoundries seeks $25 bln in IPO
$Informatica(INFA.US$ $GlobalFoundries(GFS.US$ $Fluence Energy(FLNC.US$ $Arteris(AIP.US$ $Rent the Runway(RENT.US$ $Candela Medical(CDLA.US$ $Ensemble Health Partners(ENSB.US$ $LianBio(LIAN.US$ $Solo Brands(DTC.US$ $Airsculpt Technologies(AIRS.US$ $Aura Biosciences(AURA.US$ $Entrada Therapeutics(TRDA.US$ $HireRight(HRT.US$ $Sonendo(SONX.US$ $Udemy(UDMY.US$
IPO-pedia | Chipmaker giant GlobalFoundries seeks $25 bln in IPO
$Informatica(INFA.US$ $GlobalFoundries(GFS.US$ $Fluence Energy(FLNC.US$ $Arteris(AIP.US$ $Rent the Runway(RENT.US$ $Candela Medical(CDLA.US$ $Ensemble Health Partners(ENSB.US$ $LianBio(LIAN.US$ $Solo Brands(DTC.US$ $Airsculpt Technologies(AIRS.US$ $Aura Biosciences(AURA.US$ $Entrada Therapeutics(TRDA.US$ $HireRight(HRT.US$ $Sonendo(SONX.US$ $Udemy(UDMY.US$
Expand 21
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg